戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 rmacogenomically informed, personalized, and preventive).
2 ation and begin developing and testing novel preventives.
3 occurred in 25 (32.9%) of 76 patients in the preventive ablation group and 23 (27.7%) of 83 patients
4 0%; P=0.020) were numerically reduced in the preventive ablation group.
5                         The BERLIN VT study (Preventive Ablation of Ventricular Tachycardia in Patien
6                         We hypothesized that preventive ablation strategy would be superior to deferr
7 mboembolic disease, potential diagnostic and preventive actions, and recommendations for prophylaxis
8 uggesting that angiogenin may serve as a new preventive agent and therapeutic target for IBD.
9  the epidemiological research supporting the preventive and antihypertensive effects of major lifesty
10 roving our ability to develop more effective preventive and intervention approaches.
11 s in this field moving forward toward future preventive and personalized medicine devices are also di
12 ctors with diseases is crucial for proposing preventive and regulatory actions.
13 cated multi-assay screening platform to test preventive and therapeutic antifibrotic candidates.
14 es are attractive targets for developing new preventive and therapeutic approaches including potentia
15 tic infections and epilepsy, and we consider preventive and therapeutic approaches to reduce the burd
16              These findings are relevant for preventive and therapeutic considerations and for neuroi
17 and often fatal hemorrhagic fever, for which preventive and therapeutic measures are severely limited
18       Following the implementation of simple preventive and therapeutic modalities, infant mortality
19 atforms, complementarily, in order to screen preventive and therapeutic potentials of the antiparasit
20 ted murine model of cardiac fibrosis in both preventive and therapeutic settings, as well as in the D
21 yelitis (EAE), a preclinical model of MS, in preventive and therapeutic setups.
22 e a promising target for designing effective preventive and therapeutic strategies for chronic HCV in
23 sease, transmission, and immunity to develop preventive and therapeutic strategies for people of all
24 ween obesity and asthma and to develop novel preventive and therapeutic strategies.
25 will allow the design of novel and effective preventive and therapeutic strategies.
26 oration of the gut microbiome is a promising preventive and therapeutic strategy in a number of clini
27                                     Specific preventive and therapeutic techniques should be implemen
28 how stones form and to consider possible new preventive and therapeutic treatment options.
29 inform the future development and testing of preventive and treatment interventions.
30 its definition, severity classification, and preventive and treatment strategies.
31               Such antibodies have potential preventive and/or therapeutic potential and can serve as
32                     Recently, the concept of preventive antiepileptic treatment to modify the natural
33  be harnessed to induce both therapeutic and preventive antiviral effects.
34                        These data identify a preventive approach for the onset of autoimmune disease
35                                             (Preventive Approach to Congenital Heart Block With Hydro
36 ant species warrant the development of newer preventive approaches against IC.
37  the affordability of relatively inexpensive preventive care could increase dental service utilizatio
38 -of-the-Art Review, an early and sustainable preventive care plan is described for cardiometabolic-ba
39  burden, motivating search for treatment and preventive care strategies.
40  RA receive poorer primary and secondary CVD preventive care than other high-risk patients, and an un
41 onal benefit in medical interactions to make preventive care worthwhile; (4) there are insufficient s
42 ikely to be diagnosed appropriately, receive preventive care, or be treated aggressively for CVD.
43 out using quick-relief medication or seeking preventive care.
44                        Starting and stopping preventive chemotherapy (PC) for soil-transmitted helmin
45                  Pharmaceutical donations of preventive chemotherapy for neglected tropical diseases
46                                              Preventive chemotherapy is the main strategy to control
47 m CT-guided percutaneous FICS procedures for preventive consolidation of impending femoral neck patho
48 eregrinus to predict such events and support preventive control measures.
49 fruit fly B. minax provided new insights for preventive control of this agriculture important pest an
50  of vascular factors should be considered in preventive, diagnostic, and therapeutic approaches to ad
51  mortality in sickle cell disease (SCD), but preventive, diagnostic, and therapeutic options are limi
52 echanics is fundamental for designing better preventive, diagnostic, and treatment strategies for imp
53 d our cohort to initiators of medications in preventive drug classes (statins, antiglaucoma drugs, an
54 fied predictor fasting insulin, modifies the preventive effect of bariatric surgery on MI incidence.
55                                          The preventive effect of pNPWT on SSI remained after correct
56                                  The allergy preventive effects of gut immune modulation by bacterial
57                      Previously, we reported preventive effects of Notch deficiency on the developmen
58                          We examined the HCV preventive efficacy of medication-assisted treatment (MA
59                                              Preventive efforts focused on minimizing alcohol intake
60                                         This preventive external application of high doses of NO(.) b
61 11 [standard deviation]; 35 women) underwent preventive FICS for consolidation of impending pathologi
62                                              Preventive goals are agreed, and a review appointment is
63  disease increased despite implementation of preventive guidelines.
64 re provides an avenue for the development of preventive HCV vaccine candidates that induce bNAbs at h
65 mmendation includes all clinicians providing preventive health care to women, particularly in primary
66 g, and emotional expression), greater use of preventive health care, more volunteer activities, and p
67           In addition to primary medical and preventive health care, transgender patients need access
68 ensuring equitable access to this lifesaving preventive health measure.Objectives: To outline current
69 igrants that discourages them from accessing preventive health services.
70  States experience disparities in the use of preventive health services.
71 examined population outcomes of hypothetical preventive intervention scenarios.
72 d are a promising target for therapeutic and preventive intervention.
73        Whether tuberculosis case finding and preventive interventions among previously treated people
74 ciples of mentalization-based treatments and preventive interventions and the evidence for their effe
75 nding the etiology of childhood obesity, the preventive interventions and treatment options for overw
76 gthen the call for prioritising the focus on preventive interventions at population level which could
77  such pathways provides not only support for preventive interventions but also opportunities to devel
78 reduced epidemiological risk associated with preventive interventions can be difficult to translate i
79                                              Preventive interventions for diabetes can improve cardio
80            This study confirms that diabetes preventive interventions improve CRFs regardless of CAD
81 M needs to be strengthened by focusing it on preventive interventions targeting T2DM and key risk fac
82 high-risk phenotype of patients with CRS for preventive interventions to reduce exacerbation frequenc
83 cussion, enhanced surveillance, and targeted preventive interventions to reduce the public health bur
84 prediction tools to help target patients for preventive interventions.
85 enefit the development and implementation of preventive interventions.
86 ost-effectiveness, and availability of other preventive interventions.
87 s are necessary to elaborate evidenced-based preventive interventions.
88 use of underlying conditions with a range of preventive interventions.
89 factors for self-harm is essential to inform preventive interventions.
90 ive dysfunction may not be useful targets of preventive interventions.
91 ly does not exist about the effectiveness of preventive interventions.
92 fore typhoid vaccination is recommended as a preventive measure.
93 CVD risk among women with HIV, and reinforce preventive measures (eg, smoking cessation, blood pressu
94 cision making about diagnoses, treatment, or preventive measures (isolation), provided they know the
95 -nCoV and may help epidemic surveillance and preventive measures against 2019-nCoV.IMPORTANCE The rec
96 need further research to inform curative and preventive measures against HIV/AIDS.
97 y in the chronic phase is presented to guide preventive measures and improve overall cardiometabolic
98  liver will be crucial in the development of preventive measures and treatments for end-stage liver d
99 sease (COPD) could lead to implementation of preventive measures before disease onset and halt progre
100 nd the basis for this heterogeneity, and new preventive measures could be developed based on findings
101  of Ebola virus (EBOV) is important to guide preventive measures during Ebola outbreaks.
102 s, and an unmet need exists for improved CVD preventive measures for patients with RA.
103 ated as potential treatments of, and primary preventive measures for, insomnia in postmenopausal wome
104 se, and treatment is generally restricted to preventive measures or tooth extraction.
105                          Despite widely used preventive measures such as sealant programs to control
106  need for effective antiviral therapy and/or preventive measures such as vaccines against RSV in youn
107  which carriers should undergo screening and preventive measures to reduce cancer risk.
108 o preventive measures; 3) novel non-surgical preventive measures to reduce the incidence of breast ca
109  a framework for how to initiate appropriate preventive measures when sex-specific risk factors are p
110 pathways, and targets important to effective preventive measures, and early disease control in childr
111  change, who thus have the most to gain from preventive measures, efforts to reverse the obesogenic e
112 able patients and implementation of adequate preventive measures, excessive evaluation might lead to
113                    Despite various levels of preventive measures, in 2020, many countries have suffer
114 transmission dynamics is vital for improving preventive measures, including norovirus vaccine develop
115 dings make clear that ensuring that COVID-19 preventive measures, including vaccines when available,
116 and informing stakeholders on mitigation and preventive measures.
117 as well as for evaluations of the effects of preventive measures.
118 ettings without a renewed focus on expanding preventive measures.
119 stablish early detection, and cost-effective preventive measures.
120 ho could benefit from strategies to maximize preventive measures.
121 ntermediate surrogate markers of response to preventive measures; 3) novel non-surgical preventive me
122 nts with migraine who had not benefited from preventive medications from two to four categories.
123 of 50 years, who had a documented failure of preventive medications from two to four drug categories
124 e or have not responded to multiple previous preventive medications.
125 responded to two to four classes of migraine preventive medications.
126 y care screening, behavioral counseling, and preventive medications.
127                 Vaccination is a mainstay in preventive medicine, reducing morbidity and mortality fr
128 hese dynamics has important implications for preventive medicine.
129                   We discuss disease trends, preventive opportunities offered by underlying risk fact
130                                Although some preventive options are being reported, therapeutic optio
131 ocumented VT were randomly assigned 1:1 to a preventive or deferred ablation strategy.
132 altered during old age is crucial to develop preventive or therapeutic strategies.
133 o acute (OR 12.34, 95% CI 2.51 to 64.73) and preventive (OR 16.98, 95% CI 6.88 to 45.52) treatments a
134                                The effect of preventive oral habits is largely unexplored in older in
135  nondental primary care providers delivering preventive oral health services (POHS) to young children
136 would thus be a useful prognostic marker for preventive patient management and improved healthcare re
137 c cardiovascular disease to guide the use of preventive pharmacotherapies, such as aspirin, lipid-low
138 pulation-based data will inform decisions on preventive policies and health system preparedness at th
139             We further demonstrated a direct preventive potential of Praziquantel against the onset o
140 uide personalized advice on sleep length and preventive practices.
141 derwent no intervention, while the PP group (Preventive Program) followed ergonomic principles in the
142                            The NPP group (No Preventive Program) underwent no intervention, while the
143                                We explored a preventive protocol for milk allergy with the oral admin
144 s economic and social conditions; therefore, preventive recommendations that address these determinan
145 ch others may be considered for primary care preventive recommendations.
146 oxastin-1 (Lip-1), and ACSL4 modulation in a preventive regimen were assessed in vivo and in vitro.
147 d effective risk-based allocations of scarce preventive resources, including vaccinations(1).
148 has launched a Global Initiative to scale up preventive, screening, and treatment interventions to el
149 tients with VI undergo mammography and other preventive screenings as recommended by the USPSTF.
150 e coverage or lack of a regular provider, on preventive service use had mixed and inconclusive findin
151 in the use of 10 USPSTF-recommended clinical preventive services for cancer, heart disease, and diabe
152 orce (USPSTF), recommend a range of clinical preventive services for persons at average risk for dise
153                                  The Women's Preventive Services Initiative (WPSI), a national coalit
154 ult women: a recommendation from the Women's Preventive Services Initiative.
155  vs. 46.8% for all others, p = 0.54) or U.S. Preventive Services Task Force (43.7% vs. 43.7%, p = 0.9
156 eet the age and smoking criteria of the U.S. Preventive Services Task Force (USPSTF) for annual CT lu
157                     A 2014 review for the US Preventive Services Task Force (USPSTF) found antiviral
158                      The purpose of the U.S. Preventive Services Task Force (USPSTF) is to provide ev
159                     A 2013 review for the US Preventive Services Task Force (USPSTF) of hepatitis C v
160  cancer in accordance with the United States Preventive Services Task Force (USPSTF) recommendations
161            Expert groups, including the U.S. Preventive Services Task Force (USPSTF), recommend a ran
162                                The Community Preventive Services Task Force found sufficient evidence
163                            In 2019, the U.S. Preventive Services Task Force performed an evidence rev
164                  Implementing this Community Preventive Services Task Force recommendation in communi
165         Screening for unhealthy drug use: US Preventive Services Task Force recommendation statement.
166 irus infection in adolescents and adults: US Preventive Services Task Force Recommendation Statement.
167 for cognitive impairment in older adults: US Preventive Services Task Force recommendation statement.
168                       In 2016, the Community Preventive Services Task Force released a recommendation
169                                           US Preventive Services Task Force, Owens DK, Davidson KW, e
170 vention Workshop: Achieving Health Equity in Preventive Services to assess the available evidence on
171 tinue to provide recommendations on clinical preventive services to improve the health of all America
172                   Increasing engagement with preventive services will require decreasing perceived bu
173 an, resulting in suspension of many clinical preventive services, pediatric vaccination rates in the
174 g methods outlined by the Guide to Community Preventive Services.
175 enhancing the availability of evidence-based preventive services; eliminating disparities that limit
176 need to be allocated to design and implement preventive strategies (healthy lifestyles, modifications
177                                              Preventive strategies aimed at reducing assault and fall
178 lth problem worldwide, and new therapies and preventive strategies are necessary for controlling the
179                        Novel therapeutic and preventive strategies are needed to contain the HIV-1 ep
180 acquired acute kidney injury (AKI), targeted preventive strategies are not available.
181  most common cause of cancer death in women, preventive strategies are urgently needed.
182                                      Several preventive strategies can be incorporated in surgical pr
183 se of glucocorticoids and the application of preventive strategies can minimize these adverse effects
184                                       Future preventive strategies focused on improving cardiometabol
185                           The most important preventive strategies in the primary and secondary preve
186 ther studies mainly regarding prediction and preventive strategies in this context.
187 eir potential to provide the basis for novel preventive strategies is warranted.
188                                              Preventive strategies must be implemented to minimize th
189 ikelihood of mortality from STEMI and use of preventive strategies such as preprocedural intubation i
190 ealth authorities may develop evidence-based preventive strategies to offer influenza vaccination in
191  AKI lacks effective therapeutic approaches, preventive strategies using preconditioning protocols, i
192  organism, and translational significance of preventive strategies was demonstrated in preclinical mo
193 ss considered important, including community preventive strategies, harm reduction interventions to r
194 due to advancements in immunosuppression and preventive strategies, including pretransplant infectiou
195 o tailor their prenatal management and adopt preventive strategies, such as low-dose aspirin.
196  hyperimmune globulin may provide additional preventive strategies.
197 g potential groups of interest, the focus of preventive strategies.
198 ntation is highly needed to establish guided preventive strategies.
199 need for better influenza vaccines and other preventive strategies.
200                                The KE-1 diet preventive strategy attenuated development of left ventr
201 proving sleep quality may thus represent one preventive strategy for lowering inflammatory status and
202 de decision making regarding the type of CMV preventive strategy in kidney transplantation.
203        The implementation of this multimodal preventive strategy should be considered in centers with
204 ing at an alarming rate due to an inadequate preventive strategy to protect the lens from this protis
205    The Mongolian case shows that with robust preventive systems, an effective response to a pandemic
206 inical seizure was significantly longer with preventive than conventional treatment [RCT: 364 days (9
207 ) and CMP-Kdn remain viable leads as topical preventive/therapeutic agents against the global threat
208             Food allergy is on the rise, and preventive/therapeutic procedures are needed.
209                             Trials of novel, preventive therapies are urgently needed to inform treat
210 ety of IPT and new short-course tuberculosis preventive therapies during pregnancy.
211 chemotaxis can unravel potential targets for preventive therapies in inflammatory disease conditions.
212 omes by increasing the use of evidence-based preventive therapies informed by plaque burden.
213 ying increased surveillance or even low-risk preventive therapies should these be available), identif
214 is group is paramount to optimize the use of preventive therapies.
215 veloping TB despite initiation of ART and TB preventive therapies.
216                                Cotrimoxazole preventive therapy (CPT) in human immunodeficiency virus
217                                    Isoniazid preventive therapy (IPT) is widely used to protect again
218          We also hypothesized that isoniazid preventive therapy (IPT) may revert LTBI diagnoses becau
219                                    Isoniazid preventive therapy (IPT) reduces mortality among individ
220 llow-up examinations and secondary isoniazid preventive therapy (IPT), alone and in combination, amon
221 ive either empiric TB treatment or isoniazid preventive therapy (IPT).
222 he willingness of MDR-TB HHCs to take MDR-TB preventive therapy (MDR TPT) to decrease their risk of T
223                                 Tuberculosis preventive therapy (TPT) is highly effective at preventi
224                         The effectiveness of preventive therapy against incident tuberculosis was est
225 is); and (2) estimating the effectiveness of preventive therapy and BCG vaccination on the risk of de
226 s of age, 2,106 contacts (50%) initiated INH preventive therapy at enrollment.
227  suggests the use of statins as tuberculosis preventive therapy by inhibiting PDIM spread.
228 ting, post-treatment follow-up and secondary preventive therapy can accelerate declines in tuberculos
229 f the 76 household contacts who received INH preventive therapy compared with 3% (8 of 273) of those
230 redict disease risk, and potentially predict preventive therapy efficacy.
231 following two preventive therapy strategies: preventive therapy for all household contacts, or preven
232 ntive therapy for all household contacts, or preventive therapy for only household contacts with a po
233 eatment follow-up examinations and secondary preventive therapy for tuberculosis in a tuberculosis-en
234                                              Preventive therapy for tuberculosis reduces the risk of
235 lusions: Household contacts who received INH preventive therapy had a lower incidence of tuberculosis
236 and meta-analysis showed that using MMF as a preventive therapy in NMOSD patients can significantly r
237 e-pyrimethamine (SP) is used as intermittent preventive therapy in pregnancy (IPTp) for malaria in su
238 uideline changes affected identification for preventive therapy in young adults with premature myocar
239 n.Objectives: To evaluate the effects of INH preventive therapy on the contacts of patients with mult
240 istory to model outcomes, assuming different preventive therapy regimens, ages, and TST positivity pr
241  effectiveness of contact investigations and preventive therapy remains poorly understood.
242 eruvian national guidelines specify that INH preventive therapy should be provided to contacts aged 1
243  adverse events, comparing the following two preventive therapy strategies: preventive therapy for al
244 ease in one patient, suggesting that primary preventive therapy studies on disease modification are n
245 on are needed, such as earlier initiation of preventive therapy through rapid diagnosis of adult case
246          Based on the available data, giving preventive therapy to all household contacts would proba
247 gh burden of tuberculosis that are expanding preventive therapy use must decide how tuberculosis infe
248                         The effectiveness of preventive therapy was 63% (adjusted HR 0.37 [95% CI 0.3
249                                 Short-course preventive therapy with 12 doses of once-weekly rifapent
250                       Children not receiving preventive therapy with a positive result for tuberculos
251 to better identify individuals to target for preventive therapy, predict disease risk, and potentiall
252 nd infection, yet few were receiving routine preventive therapy.
253                    Only 21 (2%) HHCs were on preventive therapy.
254 r younger, only half this group received INH preventive therapy.Measurements and Main Results: Among
255  to introduce typhoid conjugate vaccine as a preventive tool against enteric fever.
256                       Trials of intermittent preventive treatment (IPTp) of malaria in pregnant women
257 to calcitonin gene-related peptide, may be a preventive treatment for cluster headache.
258           Many patients who require migraine preventive treatment have not been able to tolerate or h
259       Understanding the role of intermittent preventive treatment in pregnancy (IPTp) on the selectio
260 imate the cost-effectiveness of intermittent preventive treatment in pregnancy with dihydroartemisini
261 insecticidal nets together with intermittent preventive treatment in pregnancy with sulfadoxine-pyrim
262 ening and treatment showed that intermittent preventive treatment is a promising alternative treatmen
263 partments to scale up the LTBI screening and preventive treatment needed to advance progress towards
264                                              Preventive treatment of malaria among school-aged childr
265  randomized controlled trial of intermittent preventive treatment of malaria in pregnancy.
266                   We aimed to assess whether preventive treatment of malaria might be an effective me
267 akers and programme managers should consider preventive treatment of malaria to protect this age grou
268  Galcanezumab was superior to placebo in the preventive treatment of migraine and was safe and well t
269  the efficacy of rimegepant with placebo for preventive treatment of migraine.
270 very other day, rimegepant was effective for preventive treatment of migraine.
271 r safety, tolerability, and efficacy for the preventive treatment of migraine.
272 , supporting its phase 3 development for the preventive treatment of migraine.
273 indings could yield the need for intensified preventive treatment of patients with diabetes mellitus
274 a spectrum disorder, a relative abundance of preventive treatment options now exists.
275 orts of 1000 women who received intermittent preventive treatment or single screening and treatment.
276     At 24 months, our pooled analysis showed preventive treatment reduced the risk of clinical seizur
277 single screening and treatment, intermittent preventive treatment resulted in an incremental cost of
278              The higher cost of intermittent preventive treatment was driven by monthly administratio
279                 No adverse events related to preventive treatment were noted.
280                                 Intermittent preventive treatment with dihydroartemisinin-piperaquine
281 esia, comparing the efficacy of intermittent preventive treatment with dihydroartemisinin-piperaquine
282 cremental cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine
283                                      Allergy-preventive treatment with OVA, nitrated OVA (nOVA), and
284 on of which primarily relies on intermittent preventive treatment with sulfadoxine-pyrimethamine (IPT
285                                              Preventive treatment with vigabatrin was safe and modifi
286 on-induced gut injury is needed to develop a preventive treatment.
287 0.0-28.0), and 232 (28%) had previously used preventive treatment.
288  protection and potentially can be used as a preventive treatment.
289 n, results-based financing, and intermittent-preventive-treatment with sulphadoxine-pyrimethamine (IP
290 havioral markers, risk prediction tools, and preventive/treatment interventions.
291 o the diagnostic end point in assessments of preventive treatments for the disorder.
292  for whom multiple previous standard-of-care preventive treatments had failed.
293 on a suitable target for Alzheimer's disease preventive treatments.
294 arrhea and community-acquired infections; no preventive vaccine is licensed.
295 s was primarily due to cross-reactivity with preventive vaccine-induced anti-feline panleukopenia vir
296                   Despite the development of preventive vaccines against HBV, a therapeutic vaccine i
297 TOP was a clinical trial designed to compare preventive versus conventional antiepileptic treatment i
298                                       In the preventive versus deferred ablation group, 6 versus 2 pa
299 ng ICD implantation, we compared outcomes of preventive VT ablation (undertaken before ICD implantati
300                                              Preventive VT ablation before ICD implantation did not r

 
Page Top